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Abstract
Aims Percutaneous coronary intervention (PCI) of bifur-
cation lesions can be performed using various techniques.
The aim of this study was to analyse the outcome of various
techniques of bifurcation stenting in all patients undergo-
ing bifurcation stenting at one large intervention centre in
2013, taking into account that more complex lesions might
more often warrant a two-stent technique.
Methods and results This retrospective study included
260 consecutive patients who underwent non-primary PCI
of a bifurcation lesion at the Catharina Hospital, Eindhoven,
in 2013. Patients were classified into two groups: one-stent
technique (provisional stenting), and two-stent techniques
(culotte, crush and T-stenting). The primary endpoint was
the rate of restenosis at 1 year. The secondary endpoints
were procedural complications (side branch occlusion,
periprocedural infarction, and death) and major adverse
cardiac events (MACE) at 1 year. Periprocedural compli-
cations occurred in 15 patients (5.8 %) with no difference
between the groups (p = 0.27). After 1 year, restenosis
occurred in 3.2 % of the patients in the one-stent technique
group and 7.3 % in the two-stent technique group (p =
0.20). MACE at 1 year did not differ between the groups
at 11.9 % and 12.2 % respectively (p = 1.00).
Conclusions This study shows that there is no signifi-
cant difference between restenosis rate, or any other out-
come parameter, with the different techniques of bifurca-
tion stenting. Since provisional stenting is the simplest,
most straightforward and cheapest approach, if technically
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feasible this technique has our preference as the initial ap-
proach, and an upgrade can be considered if the result is
insufficient.
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Introduction
Approximately 15 % of coronary stenoses are located at
a bifurcation [1]. Bifurcation lesions of epicardial coronary
arteries can be treated using several techniques [2]. Per-
cutaneous coronary intervention (PCI) with involvement of
a bifurcation lesion is associated with a worse long-term
outcome when both the main branch (MB) and side branch
(SB) are stented [3]. Recent studies show that provisional
stenting (using one stent for the MB only and ballooning
the SB) is still the recommended technique [4, 5]. Never-
theless, in one-third of cases in which patients are sched-
uled for provisional stenting in the MB, it is necessary to
implant a second stent in the SB [4]. One of the causes
is low flow or occlusion of the SB, which occurs in ap-
proximately 8 % of lesions [6]. The effect of final kissing
ballooning is also the subject of debate, in some studies it
seems to be ineffective in provisional stenting [7, 8], but
in other studies it is found to be superior when compared
with culotte, crush and T-stenting [9]. The usefulness of
bioresorbable stents in bifurcation lesions [10, 11], even as
coronary stent of choice in patients with stable angina pec-
toris and patients with unstable angina pectoris, has been
discussed previously [12].
The aim of the present study was to investigate outcome
using the various techniques of bifurcation stenting and to
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evaluate 1-year outcome in all consecutive patients in whom
bifurcation stenting was performed at one high volume re-
ferral centre in 2013.
Methods
Patient population
This retrospective study was performed at the Catharina
Hospital in Eindhoven, the Netherlands. All consecutive
patients who underwent a non-primary PCI (non-PPCI) of
a de novo coronary bifurcation stenosis during 2013 were
analysed. In this study, a procedure was defined as bifur-
cation stenting if all of the following four conditions were
fulfilled: 1) the lesion should be a de novo lesion, 2) if one
branch is occluded, an attempt should be made to open it,
3) the diameter of the SB should be larger than or equal
to 1.5 mm, and 4) the stent could not be placed in the MB
without involving the SB, or vice versa.
For this purpose, we reviewed all 2382 non-PPCI pro-
cedures performed in 2013. Of these patients, 2002 clearly
did not have a bifurcation lesion. Of the 380 possible bi-
Fig. 1 Flowchart of the study.
PCI percutaneous coronary
intervention
furcations, 260 were native bifurcation segments. Of these,
116 bifurcation segments were excluded because they were
restenotic (n = 40), the SB was narrower than 1.5 mm (n =
33), one branch was supplied by a graft (n = 21), there was
a combination with a coronary aneurysm (n = 5), only bal-
loon angioplasty had been performed (n = 4), lost to follow-
up (n = 1), refusal of one referring hospital to provide data
(n = 13), or other (n = 3) (Fig. 1).
Patients were classified into different groups and subdi-
vided with respect to location of the lesion, Medina classi-
fication and the technique of stenting ([13]; Tables 1 and 2,
Fig. 2).
Bifurcation stenting techniques
In provisional stenting it may be decided to stent the
MB only without any intervention in the SB if there is
a good thrombolysis in myocardial infarction (TIMI) flow
(Fig. 3a). If TIMI flow is too low or there has been a sig-
nificant plaque shift from the MB to the SB, a two-stent
technique should be considered.
Culotte stenting consists of implanting a stent from the
proximal MB to the distal MB. Then a second stent is placed
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Table 1 Baseline characteristics
One-stent technique (n = 219) Two-stent techniques (n = 41) p-value
Age (years) 67.4 ± 11.40 65.7 ± 12.3 0.23
Male 155 (70.8) 34 (82.9) 0.13
BMI (kg/m2) 27.6 ± 4.52 26.9 ± 5.3 0.45
Smoker 86 (39.3) 14 (34.1) 1.00
Diabetes 44 (20.1) 9 (22.0) 0.83
Family history of CAD 96 (43.8) 17 (41.5) 0.86
Dislipidaemia 119 (54.3) 21 (51.2) 0.74
Hypertension 132 (60.3) 22 (53.7) 0.49
Previous PCI 54 (24.7) 11 (26.8) 0.84
Previous CABG 16 (7.3) 2 (4.9) 0.75
Values are mean ±SD, N (%)
BMI body mass index, CABG coronary artery bypass grafting, CAD coronary artery disease, PCI percutaneous coronary intervention
Table 2 Angiographic characteristics
One-stent technique (n = 219) Two-stent techniques (n = 41) p-value
Target vessel – – 0.50
LAD/D 106 (48.4) 22 (53.7) –
CX/MO 57 (26.0) 13 (31.7) –
LMCA/LAD/CX 40 (18.3) 4 (9.8) –
RCA/RDP/PL 16 (7.3) 2 (4.9) –
Vessel diameters – – –
Proximal diameter MB (mm) 3.2 ± 0.62 3.2 ± 0.57 0.84
Distal diameter MB (mm) 3.1 ± 0.60 3.0 ± 0.48 0.68
SB diameter (mm) 2.2 ± 0.54 2.6 ± 0.55 <0.001
Medina classification – – <0.001
True bifurcations 119 (54.3) 41 (100.0) –
Non-true bifurcations 100 (45.7) 0 (0.0) –
Values are mean ±SD, N (%)
CX circumflex, D diagonal, LAD left anterior descending, LMCA left main coronary artery, MB main branch, MO margo obtusus,
PL posterolateral, RCA right coronary artery, RDP ramus descending posterior, SB side branch
True bifurcations refer to Medina classification 1-1-1; 1-0-1 and 0-1-1, whereas non-true bifurcations refer to Medina classification 1-1-0; 1-0-0;
0-1-0 and 0-0-1
Fig. 2 Bifurcation lesions
according to location in the
coronary tree. CX circumflex,
D diagonal, LAD left anterior de-
scending, LMCA left main coro-
nary artery, MO margo obtusus,
PL posterolateral, RCA right
coronary artery, RDP ramus
descending posterior
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Fig. 3 Techniques of stenting.
Provisional (a), culotte (b),
crush (c) and T-stenting (d). The
blue arrows represent the layer
of struts of the main branch stent
and the red arrows represents
the layer of struts of the side
branch stent
from the proximal MB towards the SB through the struts
of the first stent. Other operators prefer to stent the SB first
and then the MB. This results in a double layer of struts in
the proximal MB and presence of struts in the SB (Fig. 3b).
Crush stenting consists of advancing two stents simulta-
neously into both the MB and SB. The proximal segment
of the SB stent is first deployed in the MB, and then it is
crushed against the wall of the main vessel during deploy-
ment of the MB stent. Crush stenting results in a triple
layer of struts in the proximal MB (Fig. 3c).
In T-stenting, one stent is implanted in the MB and one
stent at the SB. In this technique, there is no strut overlap
at any site of the bifurcation. The struts at the orifice of
the SB are intentionally removed. This technique is only
possible if the SB branches off at an angle of >45º (Fig. 3d).
Procedures
All procedures were performed according to the usual rou-
tine, either by the femoral or the radial approach. The
choice of treatment technique was either discussed by the
Heart Team prior to the procedure, or left to the discre-
tion of the operator. Second generation drug eluting stents
(DES) were used wherever possible and dual antiplatelet
therapy was recommended for at least 1 year. Treatment
and follow-up were in accordance with normal routine.
Endpoints and follow-up
The primary endpoint was the rate of restenosis at 1 year,
defined as >50 % stenosis on visual estimation in one of
the branches at follow-up angiography, driven by recurrent
angina pectoris or acute coronary syndrome. Secondary
endpoints were MACE at 1 year (defined as the compos-
ite of death, myocardial infarction (MI) and target vessel
revascularisation (TVR) by re-PCI or coronary artery by-
pass grafting (CABG)) at 1 year, the individual components
of MACE, procedural complications such as SB occlusion,
failure to dilate or to stent one of the branches, peripro-
cedural infarction (>3 times the normal range of CK-MB
or troponin-T) or death (Table 3). Angiography was only
performed in the event of recurring symptoms.
Statistical analysis
Baseline characteristics were compared depending on nor-
mal distribution. Continuous variables were analysed using
an unpaired T-test and Mann-Whitney U test. Continuous
variables are expressed as mean ± 1 SD and dichotomous
variables are expressed as absolute numbers and percent-
ages (%). Categorical variables were analysed with a chi-
square test or Fisher’s exact test if appropriate. A p-value
less than 0.05 was considered significant, and applicable
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Table 3 Periprocedural com-
plication rate, 1-year restenosis
rate and MACE at 1 year com-







Periprocedural complication rate – – 0.27
Death 2 (0.9) 1 (2.4) –
MI 8 (3.7) 3 (7.3) –
TVR 1 (0.5) 0 (0.0) –
1-year restenosis rate 7 (3.2) 3 (7.3) 0.20
MACE at 1 year – – 1.00
Death 12 (5.5) 3 (7.3) –
MI 6 (2.7) 1 (2.4) –
TVR 12 (5.5) 3 (7.3) –
Values are N (%)
MACE major adverse cardiac events, MI myocardial infarction, TVR target vessel revascularisation
tests were always two-sided. All analyses were conducted
using SPSS 22.0 software (IBM corporation, Armonk, NY).
Results
Baseline characteristics and angiographic findings
A total of 260 patients who underwent a bifurcation steno-
sis PCI at the Catharina Hospital in 2013 and fulfilled the
inclusion criteria were enrolled (Fig. 1).
Mean age was 67 ± 11 years; 189 men (73.0 %) and
71 women (27.0 %) were included. Of the 260 bifurcations
there were 128 LAD/D, 70 CX/MO, 44 LMCA/LAD/CX
and 18 RCA/RDP/PL segments involved (Fig. 2). Patients
were divided into two groups according to the technique
used (one-stent technique versus two-stent techniques).
There were no significant differences in baseline charac-
teristics (age, sex, risk factors and medical history), nor in
the diameter of the proximal and distal MB (p = 0.84 and
p = 0.68). The diameter of the SB was significantly larger
in the two-stent technique group (p < 0.001). The two-
stent technique group was more often classified as Medina
1-1-1 when compared with other techniques (p < 0.001)
(Tables 1 and 2).
Procedural characteristics
A total of 219 patients were treated by the one-stent tech-
nique and 41 by a two-stent technique (20 by culotte, 13 by
crush and 8 by T-stenting). Eleven periprocedural events
(5.0 %) occurred in the one-stent technique group, and four
(9.8 %) in the two-stent technique group (p = 0.27).
Restenosis rate at 1 year
Symptomatic restenosis occurred in 10 patients (3.8 %). Of
these, 7 patients (3.2 %) were treated by the one-stent tech-
nique and 3 (7.3 %) by a two-stent technique (p = 0.20)
(Table 3).
MACE at 1 year
MACE occurred in 26 patients (11.9 %) in the one-stent
technique versus 5 patients (12.2 %) in the group using
a two-stent technique (p = 1.00) (Table 3). Fifteen patients
(5.8 %) died within 1 year of follow-up: 12 (5.5 %) of them
in the one-stent technique group and 3 (7.3 %) in the two-
stent technique group (p = 0.71). Of these patients, 12 died
of a cardiac cause: 9 in the one-stent technique group and
3 in the two-stent technique group (p = 0.41). Late MI
occurred in 6 patients (2.7 %) in the one-stent technique
group versus 1 in the two-stent technique group (2.4 %, p =
1.00). No significant difference was found in the rates of
TVR comparing the one-stent versus the two-stent tech-
niques (5.5 % vs 7.3 %, p = 0.71).
Discussion and limitations
This study shows that in our population of 260 consecu-
tive patients undergoing bifurcation stenting in a de novo
lesion, there is no difference in restenosis rate at 1 year be-
tween provisional stenting (one-stent technique) and two-
stent techniques. Neither did we find any differences in
other adverse events such as procedural complications and
total MACE at 1 year.
Our findings are not completely in accordance with other
bifurcation studies. Over recent years several studies have
compared bifurcation stenting techniques with mutually
conflicting results. Comparing our results with those of
other studies should be done with caution due to differences
in baseline characteristics. Hildick-Smith et al. showed that
two-stent techniques resulted in higher rates of MACE both
in-hospital and at 9 months [5]. However, the inclusion
and exclusion criteria in their study were different from
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those in our study. SB diameter had to be bigger than in
our study and the left main coronary artery was excluded.
The DKCRUSH II trial did not show a difference in
MACE between provisional stenting and crush stenting,
but did show a significantly higher rate of TVR in the
provisional group (p = 0.017) [18]. In our study, we did
not find a significant difference in MACE between provi-
sional (one-stent technique) and non-provisional stenting
(two-stent techniques).
In our study, provisional stenting was mostly preferred
and SB was not stented if not necessary. This is in accor-
dance with recent consensus of the European Bifurcation
Club. They recommend MB stenting with provisional SB
treatment for the majority of bifurcation lesions, whereas
only a large SB with significant ostial disease is likely to
require a two-stent strategy [2]. Also the angle between
MB and SB is sometimes used to determine which strategy
is used [14].
The Nordic Bifurcation Study showed that two-stent
techniques are associated with a longer procedure, re-
quiring more fluoroscopy time and volume of contrast,
and associated with a greater rate of procedure-related
biomarker release [15].
Zamani et al. and Colombo et al. showed superiority of
stenting an SB with DES. In their study, TVR, deaths and
myocardial infarctions occurred less often in SB stenting
with DES than with bare-metal stents [16, 17].
There are some specific strengths of this study that
should be mentioned. In the first place, this study was
performed within one single high volume centre at which
2382 non-PPCIs were performed in 1 year. Second, all con-
secutive patients were enrolled without a single exception
and had a complete follow-up of 1 year. Third, almost all
characteristics of the patients were complete. Fourth, there
was no difference in baseline characteristics which ensures
that our results are not influenced by selective inclusion of
patients in either of the groups and the data at follow-up
were almost completely available.
Our study has also some limitations. First, because of the
retrospective nature of this study, it was not always possi-
ble to determine which of the patients treated by a two-stent
technique were initially planned to be treated so and who
underwent a two-stent technique after failure to achieve
a satisfying result by provisional stenting [19]. Second,
angiographic follow-up was driven by angina pectoris and
acute coronary syndrome and the rates of restenosis and
MACE were small. Third, in this population only a minority
of patients were treated with a two-stent technique. Signif-
icant difference in procedural complications and restenosis
at follow-up can therefore be missed due to underpower.
Finally, where baseline characteristics are concerned, it can
be suggested that the anatomy in the two-stent group was
on average more complex than in the one-stent group. In
this context, we should emphasise that our study is not in-
tended to compare the specific merits of the different stent
techniques, or to attack one of them. It just concludes that
if, for whatever reason or consideration by the operator or
Heart Team, a one-stent technique can be tried as first op-
tion, this is preferable. It does explicitly not exclude that
in some lesions a two-stent technique might perform better.
But, wherever it is possible to keep it simple, it should be
kept simple.
Despite these limitations, we believe that this retrospec-
tive analysis is representative for bifurcation stenting in
every day practice.
Conclusion
In conclusion, this study shows that in our series there is no
difference in restenosis rates between provisional stenting
compared with two-stent techniques for bifurcation stent-
ing, taking into account that more complex lesions may
more often warrant a two-stent technique. Therefore, since
provisional stenting is the simplest, most straightforward
and cheapest approach, if technically feasible this technique
has our preference as the initial approach and an upgrade
can be considered if an insufficient result is obtained.
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